Inovio Pharmaceuticals Investors Face Deadline in Securities Fraud Lawsuit
Investors who purchased Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023, and December 26, 2025, may be eligible to join a class action lawsuit. A lead plaintiff deadline of April 7, 2026, has been set, according to Rosen Law Firm, a global investor rights firm.
What’s at Stake? Allegations of Misleading Statements
The lawsuit alleges that Inovio Pharmaceuticals made false and/or misleading statements regarding its CELLECTRA device manufacturing and the potential approval timeline for its INO-3107 drug. Specifically, the claims center around concerns that:
- Manufacturing processes for the CELLECTRA device were deficient.
- The company was unlikely to submit a Biologics License Application (BLA) for INO-3107 to the FDA by the second half of 2024.
- Inovio lacked sufficient data to support accelerated or priority review by the FDA.
- The overall regulatory and commercial prospects of INO-3107 were overstated.
These alleged misrepresentations, if proven, could have led investors to suffer damages when the true details came to light.
Who is Rosen Law Firm and Why Should Investors Pay Attention?
Rosen Law Firm is actively soliciting investors to potentially serve as lead plaintiff in the case. The firm emphasizes its experience in securities class actions and shareholder derivative litigation, highlighting a track record of success, including achieving the largest ever securities class action settlement against a Chinese Company and being ranked No. 1 by ISS Securities Class Action Services in 2017 for the number of settlements achieved. They caution investors to carefully select legal counsel, noting that some firms act as “middlemen” rather than directly litigating cases.
Understanding Class Action Lawsuits and Lead Plaintiffs
A class action lawsuit allows a group of investors who have suffered similar losses to collectively pursue legal action. The lead plaintiff represents the interests of all class members. If you wish to serve as lead plaintiff, you must file a motion with the Court no later than April 7, 2026.
How Can Investors Participate?
Investors who purchased Inovio securities during the specified Class Period can explore their options by:
- Visiting https://rosenlegal.com/submit-form/?case_id=52847
- Calling Phillip Kim, Esq., toll-free at 866-767-3653
- Emailing [email protected]
It’s important to note that participation does not require out-of-pocket fees, as the firm operates on a contingency fee arrangement.
The Rise of Securities Class Action Lawsuits: A Growing Trend
Securities class action lawsuits have become increasingly common in recent years, reflecting heightened investor awareness and scrutiny of corporate disclosures. Several factors contribute to this trend:
- Increased Market Volatility: Periods of market turbulence often expose vulnerabilities in company performance and lead to investor losses.
- Complex Financial Instruments: The growing complexity of financial products can make it difficult for investors to fully understand the risks involved.
- Regulatory Scrutiny: Increased regulatory oversight and enforcement actions can uncover instances of corporate misconduct.
Pro Tip:
Don’t delay if you believe you may have been affected by this lawsuit. The lead plaintiff deadline is a firm date, and missing it could impact your ability to participate in any potential recovery.
FAQ
Q: What is a “Class Period”?
A: The Class Period refers to the specific timeframe during which investors may have been harmed by the alleged misconduct. In this case, it’s October 10, 2023, to December 26, 2025.
Q: Do I need to hire my own lawyer?
A: No, you can remain an absent class member and do nothing at this time. Though, you have the option to select your own counsel if you prefer.
Q: Will I have to pay anything to join the lawsuit?
A: No, Rosen Law Firm operates on a contingency fee basis, meaning you will not pay any out-of-pocket fees or costs.
Q: What does it mean to be a “lead plaintiff”?
A: The lead plaintiff is the representative party who directs the litigation on behalf of all class members.
Q: Is there a guarantee of recovery?
A: No, there is no guarantee of recovery in any class action lawsuit. The outcome depends on the specific facts of the case and the evidence presented.
Follow Rosen Law Firm for updates on LinkedIn, Twitter, or Facebook.
Attorney Advertising. Prior results do not guarantee a similar outcome.
